Cargando…

The Potential Role of Small-Molecule PERK Inhibitor LDN-0060609 in Primary Open-Angle Glaucoma Treatment

Primary open-angle glaucoma (POAG) constitutes the most common type of glaucoma. Emerging evidence suggests that Endoplasmic Reticulum (ER) stress and the protein kinase RNA-like endoplasmic reticulum kinase (PERK)-mediated Unfolded Protein Response (UPR) signaling pathway play a key role in POAG pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rozpędek-Kamińska, Wioletta, Galita, Grzegorz, Siwecka, Natalia, Carroll, Steven L., Diehl, John Alan, Kucharska, Ewa, Pytel, Dariusz, Majsterek, Ireneusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123501/ https://www.ncbi.nlm.nih.gov/pubmed/33925820 http://dx.doi.org/10.3390/ijms22094494

Ejemplares similares

The PERK-Dependent Molecular Mechanisms as a Novel Therapeutic Target for Neurodegenerative Diseases
por: Rozpędek-Kamińska, Wioletta, et al.
Publicado: (2020)

Inhibition of Protein Aggregation and Endoplasmic Reticulum Stress as a Targeted Therapy for α-Synucleinopathy
por: Siwecka, Natalia, et al.
Publicado: (2023)

The Structure, Activation and Signaling of IRE1 and Its Role in Determining Cell Fate
por: Siwecka, Natalia, et al.
Publicado: (2021)

IRE1α Inhibitors as a Promising Therapeutic Strategy in Blood Malignancies
por: Wiese, Wojciech, et al.
Publicado: (2022)

Targeting NLRP3-Mediated Neuroinflammation in Alzheimer’s Disease Treatment
por: Barczuk, Julia, et al.
Publicado: (2022)

GBA1 Gene Mutations in α-Synucleinopathies—Molecular Mechanisms Underlying Pathology and Their Clinical Significance
por: Granek, Zuzanna, et al.
Publicado: (2023)

Tumor progression and the Different Faces of the PERK kinase
por: Pytel, Dariusz, et al.
Publicado: (2015)

Dual role of Endoplasmic Reticulum Stress-Mediated Unfolded Protein Response Signaling Pathway in Carcinogenesis
por: Siwecka, Natalia, et al.
Publicado: (2019)

The Genetic and Endoplasmic Reticulum-Mediated Molecular Mechanisms of Primary Open-Angle Glaucoma
por: Rozpędek-Kamińska, Wioletta, et al.
Publicado: (2020)

Synthesis and Hemostatic Activity of New Amide Derivatives
por: Banach, Lukasz, et al.
Publicado: (2022)

The Cytotoxicity and Genotoxicity of Three Dental Universal Adhesives—An In Vitro Study
por: Wawrzynkiewicz, Adam, et al.
Publicado: (2020)

The Toxicity of Universal Dental Adhesives: An In Vitro Study
por: Wawrzynkiewicz, Adam, et al.
Publicado: (2021)

Molecular Mechanisms Underlying NMDARs Dysfunction and Their Role in ADHD Pathogenesis
por: Kuś, Justyna, et al.
Publicado: (2023)

The Cytotoxicity and Genotoxicity of Bioactive Dental Materials
por: Kunert, Marta, et al.
Publicado: (2022)

PI3K/Akt/mTOR Signaling Pathway in Blood Malignancies—New Therapeutic Possibilities
por: Wiese, Wojciech, et al.
Publicado: (2023)

Physico-Chemical Properties and Biocompatibility of Thermosensitive Chitosan Lactate and Chitosan Chloride Hydrogels Developed for Tissue Engineering Application
por: Pieklarz, Katarzyna, et al.
Publicado: (2021)

Analysis of the Expression and Polymorphism of APOE, HSP, BDNF, and GRIN2B Genes Associated with the Neurodegeneration Process in the Pathogenesis of Primary Open Angle Glaucoma
por: Nowak, Alicja, et al.
Publicado: (2015)

PERK Is a Haploinsufficient Tumor Suppressor: Gene Dose Determines Tumor-Suppressive Versus Tumor Promoting Properties of PERK in Melanoma
por: Pytel, Dariusz, et al.
Publicado: (2016)

Altered Expression Levels of MMP1, MMP9, MMP12, TIMP1, and IL-1β as a Risk Factor for the Elevated IOP and Optic Nerve Head Damage in the Primary Open-Angle Glaucoma Patients
por: Markiewicz, Lukasz, et al.
Publicado: (2015)

BDNF and HSP gene polymorphisms and their influence on the progression of primary open-angle glaucoma in a Polish population
por: Nowak, Alicja, et al.
Publicado: (2014)

Interplay between Redox Signaling, Oxidative Stress, and Unfolded Protein Response (UPR) in Pathogenesis of Human Diseases
por: Poplawski, Tomasz, et al.
Publicado: (2019)

Lutein and Zeaxanthin and Their Roles in Age-Related Macular Degeneration—Neurodegenerative Disease
por: Mrowicka, Małgorzata, et al.
Publicado: (2022)

Relationship between the Occurrence of Genetic Variants of Single Nucleotide Polymorphism in microRNA Processing Genes and the Risk of Developing Multiple Sclerosis
por: Basak, Justyna, et al.
Publicado: (2022)

Association of MMP1-1607 1G/2G and TIMP1 372 T/C gene polymorphisms with risk of primary open angle glaucoma in a Polish population
por: Majsterek, Ireneusz, et al.
Publicado: (2011)

Screening of Self-Assembling of Collagen IV Fragments into Stable Structures Potentially Useful in Regenerative Medicine
por: Kolasa, Marcin, et al.
Publicado: (2021)

PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage
por: Bobrovnikova-Marjon, Ekaterina, et al.
Publicado: (2010)

Polymorphisms in DNA Repair Genes and Association with Rheumatoid Arthritis in a Pilot Study on a Central European Population
por: Galita, Grzegorz, et al.
Publicado: (2023)

Association of miRNA and mRNA Levels of the Clinical Onset of Multiple Sclerosis Patients
por: Piotrzkowska, Danuta, et al.
Publicado: (2021)

Low-Dose Naltrexone (LDN)—Review of Therapeutic Utilization
por: Toljan, Karlo, et al.
Publicado: (2018)

Association of Polymorphic Variants in Argonaute Genes with Depression Risk in a Polish Population
por: Kowalczyk, Mateusz, et al.
Publicado: (2022)

RNA-Based Liquid Biopsy in Head and Neck Cancer
por: Kabzinski, Jacek, et al.
Publicado: (2023)

Jessica Soldavini, MPH, RD, LDN, Wins Huddleson Award
Publicado: (2020)

Association between the Cytosine Hydroxymethylation and the Expression of microRNA in Multiple Sclerosis in Polish Population
por: Basak, Justyna, et al.
Publicado: (2023)

Exploring the mRNA and Plasma Protein Levels of BDNF, NT4, SIRT1, HSP27, and HSP70 in Multiple Sclerosis Patients and Healthy Controls
por: Sokolowski, Igor, et al.
Publicado: (2023)

Small Molecules Dorsomorphin and LDN-193189 Inhibit Myostatin/GDF8 Signaling and Promote Functional Myoblast Differentiation
por: Horbelt, Daniel, et al.
Publicado: (2015)

Treatment-resistant immune thrombocytopenic purpura associated with LDN use in a patient with MS
por: Torkildsen, Øivind, et al.
Publicado: (2014)

Treatment of Complex Regional Pain Syndrome (CRPS) Using Low Dose Naltrexone (LDN)
por: Chopra, Pradeep, et al.
Publicado: (2013)

The Bone Morphogenetic Protein Signaling Inhibitor LDN-193189 Enhances Metastasis Development in Mice
por: Vollaire, Julien, et al.
Publicado: (2019)

The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain
por: Younger, Jarred, et al.
Publicado: (2014)

Structural basis for the potent and selective binding of LDN-212854 to the BMP receptor kinase ALK2
por: Williams, Eleanor, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_smk39dv31keo0ap9721hilv2et